HCA Healthcare Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $74.70B | $70.20B | $65.00B | $60.20B | $58.40B | $51.50B | $51.30B | $46.70B |
| Inpatient Services | $39.50B | $37.20B | $34.60B | $32.50B | $31.20B | $27.50B | $28.20B | $26.40B |
| Outpatient Services | $27.20B | $25.50B | $23.50B | $21.80B | $21.00B | $18.00B | $18.70B | $17.00B |
| Other Operating Revenue | $8.00B | $7.50B | $6.90B | $5.90B | $6.20B | $6.00B | $4.40B | $3.30B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $548.0M | $421.0M | $353.0M | $307.0M | $337.0M | $416.0M | $370.0M | $344.0M |
| Operating Income | $12.08B | $10.58B | $9.64B | $10.32B | $11.40B | $7.01B | $7.07B | $7.09B |
| Operating Margin | 16.2% | 15.1% | 14.8% | 17.1% | 19.5% | 13.6% | 13.8% | 15.2% |
| Interest Expense | $2.25B | $2.06B | $1.94B | $1.74B | $1.57B | $1.58B | $1.82B | $1.76B |
| Pretax Income | $9.83B | $8.52B | $7.71B | $8.58B | $9.83B | $5.43B | $5.24B | $5.34B |
| Income Tax Expense | $2.05B | $1.87B | $1.62B | $1.75B | $2.11B | $1.04B | $1.10B | $946.0M |
| Net Income | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B | $3.75B | $3.51B | $3.79B |
| Net Margin | 9.1% | 8.2% | 8.1% | 9.4% | 11.9% | 7.3% | 6.8% | 8.1% |
| EPS (Basic) | $28.70 | $22.27 | $19.25 | $19.43 | $21.52 | $11.10 | $10.27 | $10.90 |
| EPS (Diluted) | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 | $10.93 | $10.07 | $10.66 |
| Shares Outstanding (Basic) | 236.4M | 258.6M | 272.4M | 290.3M | 323.3M | 338.3M | 341.2M | 347.3M |
| Shares Outstanding (Diluted) | 239.5M | 261.8M | 276.4M | 294.7M | 328.8M | 343.6M | 348.2M | 355.3M |
| Dividends Per Share | $2.88 | $2.64 | $2.40 | $2.24 | $1.92 | $0.43 | $1.60 | $1.40 |